Results 141 to 150 of about 172,168 (267)
Chronic Myeloid Leukemia with Rare e1a3 BCR-ABL Transcript
Chronic myelogenous leukemia (CML) results from neoplastic transformation of a hematopoietic stem cell. It is cytogenetically characterized by the presence of Philadelphia chromosome which results from reciprocal translocation t(9;22) that juxtaposes ...
Najia Tabassum +3 more
doaj
BACKGROUND AND OBJECTIVES: Cytotoxic T-lymphocytes (CTL) have been generated in vitro against chronic myeloid leukemia (CML)-associated BCR/ABL-specific peptides.
EF Posthuma +9 more
doaj
Immunogenicity of BCR-ABL-regulated tumorantigens
Im Hinblick auf die Entwicklung alternativer, immuntherapeutischer Ansätze zur Behandlung der Ph-positiven chronisch myeloischen Leukämie (CML) wurde in der vorliegenden Arbeit die Immunogenität des BCR-ABL-Fusionsproteins selbst, und der durch die BCR ...
Scheich, Florian
core
Specific inhibition of bcr-abl gene expression by small interfering RNA
Small interfering RNAs (siRNAs) were designed to target the bcr-abl oncogene, which causes chronic myeloid leukemia (CML) and bcr-abl-positive acute lymphoblastic leukemia (ALL).
Ganser A +5 more
core +2 more sources
Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects
BACKGROUND AND OBJECTIVES: The fusion oncoprotein bcr-abl that characterizes chronic myeloid leukemia (CML) is a leukemia-specific antigen, which may be immunogenic in vivo.
NM Butt +5 more
doaj
e8a2 BCR–ABL: more frequent than other atypical BCR–ABL variants? [PDF]
DEMEHRI S +12 more
openaire +2 more sources
Bei ca. 95% der chronisch myeloischen Leukämie (CML) und 20-30% der akuten lymphatischen Leukämie (ALL) des Erwachsenen liegt eine reziproke Chromosomentranslokation t(9;22)(q34;q11) vor, in deren Rahmen das BCR (Breakpoint Cluster Region) Gen auf ...
Rafiei, Anahita (Dr.)
core
BCR-ABL kinase mutations may confer resistance to imatinib in patients with chronic myeloid leukemia (CML), and may predict a poor outcome. We investigated whether rises in BCR-ABL transcript levels predicted mutation development in 82 CML patients ...
L Wang, K Knight, C Lucas, RE Clark
doaj

